Researcher on issues related to surgical site infections and other surgical-related outcomes, hospital acquired infections, influenza, Clostridium difficile, and vaccination of adult patients with cancer.
Dr Diana Vilar-Compte received her MD and MSc (Epidemiology) from Universidad Nacional Autónoma de Mexico, where she graduated with honours. She trained in Internal Medicine, and obtained a diploma in health quality of care from Universidad de Murcia, Spain. She’s appointed as Professor at the Infectious Diseases Department at Instituto Nacional de Cancerologia in Mexico City. She is Adjunct Lecturer of Clinical Epidemiology and Evidence Based Medicine at Universidad Nacional Autónoma de México. She’s currently a professor and tutor of undergraduate, Master’s and Doctoral Program for the school. Since 2005, has been appointed as a National Researcher by the National Research Council (CONACYT). In 2008, she was admitted into Mexico’s National Academy of Medicine.
Dr Vilar-Compte’s has focused on issues related to surgical site infections and other surgical-related outcomes, hospital acquired infections, influenza, Clostridium difficile, and vaccination of adult patients with cancer. During the pandemic influenza, she was actively involved from the beginning of the epidemic in Mexico City, and contributed on different aspects related to hospital reorganization, vaccination and response. Dr Vilar-Compte has authored 54 scientific papers in these areas and has contributed to various chapters in medical textbooks concerning the prevention and management of surgical infections, influenza, and topics related to hospital-acquired infections. Her scientific publications have been cited more than 600 times.
She belongs to the Mexican Association of Infectious Diseaseas and Clinical Microbiology, the Mexican Infection Control Association, The American Society of Microbiology and The Society for Healthcare Epidemiology (SHEA) of America. In 2014 she was selected as an International Ambassador by SHEA. From 2014 to 2016 she served as part of the American Journal of Infection Control editorial board.
Speaker at session 11 24th November: "Nosocomial and community acquired diseases and their prevention Infections control in patients with cancer"